| Dr Francis Allen Long Jr, MD | |
|
421 Cox Blvd, Sheffield, AL 35660-4021 | |
| (256) 386-7040 | |
| (256) 383-7808 |
| Full Name | Dr Francis Allen Long Jr |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 45 Years |
| Location | 421 Cox Blvd, Sheffield, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790985133 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 10880 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Helen Keller Hospital | Sheffield, AL | Hospital |
| North Alabama Medical Center | Florence, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shoals Primary Care, Llc | 1557406246 | 43 |
News Archive
A group of 40 students are part of Saint Louis University's Student National Medical Association chapter (SNMA), who are striving to reduce health disparities locally. This year, they received the Leadership in Institutional Diversity Award, a recognition given to a university for serving as an outstanding example of leadership and innovation in promoting and maintaining institutional diversity.
HAL Allergy B.V. today announced that it has successfully completed patient enrollment in its Phase II dose range finding study. This multi-centre, randomized, double-blind, placebo-controlled study in 250 patients with persistent allergic rhinitis / rhinoconjunctivitis will characterize the dose-response relationship of PURETHAL Mites in order to support the optimal dose in terms of clinical efficacy and safety.
EntreMed, Inc. a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced that it has received a letter from the NASDAQ Stock Market indicating that it has regained compliance with the minimum $35 million Market Value of Listed Securities requirement for continued listing on the NASDAQ Capital Market as set forth in NASDAQ Marketplace Rule 5550(b)(2).
In Virginia, The Washington Post traces the behind-the-scenes deal-making to create a job for the Democrat state lawmaker whose resignation gave Republicans control of the chamber and the ability to block Gov. Terry McAuliffe's plan to expand Medicaid. Meanwhile, a Missouri hospital lays off 60 employees, blaming the state's failure to expand Medicaid.
A study published in Science Translational Medicine shows that small molecules that specifically inhibit an important selenium-containing enzyme may be useful in combating cancer. When researchers at Karolinska Institutet treated cancer in mice using these molecules, they observed rapid tumoricidal effects.
› Verified 6 days ago
| Entity Name | Shoals Primary Care, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326373861 PECOS PAC ID: 1557406246 Enrollment ID: O20100305000357 |
News Archive
A group of 40 students are part of Saint Louis University's Student National Medical Association chapter (SNMA), who are striving to reduce health disparities locally. This year, they received the Leadership in Institutional Diversity Award, a recognition given to a university for serving as an outstanding example of leadership and innovation in promoting and maintaining institutional diversity.
HAL Allergy B.V. today announced that it has successfully completed patient enrollment in its Phase II dose range finding study. This multi-centre, randomized, double-blind, placebo-controlled study in 250 patients with persistent allergic rhinitis / rhinoconjunctivitis will characterize the dose-response relationship of PURETHAL Mites in order to support the optimal dose in terms of clinical efficacy and safety.
EntreMed, Inc. a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced that it has received a letter from the NASDAQ Stock Market indicating that it has regained compliance with the minimum $35 million Market Value of Listed Securities requirement for continued listing on the NASDAQ Capital Market as set forth in NASDAQ Marketplace Rule 5550(b)(2).
In Virginia, The Washington Post traces the behind-the-scenes deal-making to create a job for the Democrat state lawmaker whose resignation gave Republicans control of the chamber and the ability to block Gov. Terry McAuliffe's plan to expand Medicaid. Meanwhile, a Missouri hospital lays off 60 employees, blaming the state's failure to expand Medicaid.
A study published in Science Translational Medicine shows that small molecules that specifically inhibit an important selenium-containing enzyme may be useful in combating cancer. When researchers at Karolinska Institutet treated cancer in mice using these molecules, they observed rapid tumoricidal effects.
› Verified 6 days ago
| Entity Name | Ear Nose And Throat Associates Of |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063838167 PECOS PAC ID: 0042436644 Enrollment ID: O20140716001762 |
News Archive
A group of 40 students are part of Saint Louis University's Student National Medical Association chapter (SNMA), who are striving to reduce health disparities locally. This year, they received the Leadership in Institutional Diversity Award, a recognition given to a university for serving as an outstanding example of leadership and innovation in promoting and maintaining institutional diversity.
HAL Allergy B.V. today announced that it has successfully completed patient enrollment in its Phase II dose range finding study. This multi-centre, randomized, double-blind, placebo-controlled study in 250 patients with persistent allergic rhinitis / rhinoconjunctivitis will characterize the dose-response relationship of PURETHAL Mites in order to support the optimal dose in terms of clinical efficacy and safety.
EntreMed, Inc. a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced that it has received a letter from the NASDAQ Stock Market indicating that it has regained compliance with the minimum $35 million Market Value of Listed Securities requirement for continued listing on the NASDAQ Capital Market as set forth in NASDAQ Marketplace Rule 5550(b)(2).
In Virginia, The Washington Post traces the behind-the-scenes deal-making to create a job for the Democrat state lawmaker whose resignation gave Republicans control of the chamber and the ability to block Gov. Terry McAuliffe's plan to expand Medicaid. Meanwhile, a Missouri hospital lays off 60 employees, blaming the state's failure to expand Medicaid.
A study published in Science Translational Medicine shows that small molecules that specifically inhibit an important selenium-containing enzyme may be useful in combating cancer. When researchers at Karolinska Institutet treated cancer in mice using these molecules, they observed rapid tumoricidal effects.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Francis Allen Long Jr, MD 421 Cox Blvd, Sheffield, AL 35660-4021 Ph: (256) 386-7040 | Dr Francis Allen Long Jr, MD 421 Cox Blvd, Sheffield, AL 35660-4021 Ph: (256) 386-7040 |
News Archive
A group of 40 students are part of Saint Louis University's Student National Medical Association chapter (SNMA), who are striving to reduce health disparities locally. This year, they received the Leadership in Institutional Diversity Award, a recognition given to a university for serving as an outstanding example of leadership and innovation in promoting and maintaining institutional diversity.
HAL Allergy B.V. today announced that it has successfully completed patient enrollment in its Phase II dose range finding study. This multi-centre, randomized, double-blind, placebo-controlled study in 250 patients with persistent allergic rhinitis / rhinoconjunctivitis will characterize the dose-response relationship of PURETHAL Mites in order to support the optimal dose in terms of clinical efficacy and safety.
EntreMed, Inc. a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced that it has received a letter from the NASDAQ Stock Market indicating that it has regained compliance with the minimum $35 million Market Value of Listed Securities requirement for continued listing on the NASDAQ Capital Market as set forth in NASDAQ Marketplace Rule 5550(b)(2).
In Virginia, The Washington Post traces the behind-the-scenes deal-making to create a job for the Democrat state lawmaker whose resignation gave Republicans control of the chamber and the ability to block Gov. Terry McAuliffe's plan to expand Medicaid. Meanwhile, a Missouri hospital lays off 60 employees, blaming the state's failure to expand Medicaid.
A study published in Science Translational Medicine shows that small molecules that specifically inhibit an important selenium-containing enzyme may be useful in combating cancer. When researchers at Karolinska Institutet treated cancer in mice using these molecules, they observed rapid tumoricidal effects.
› Verified 6 days ago
Mrs. Pamela D Mcgarrah, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1100 S Jackson Hwy Ste 250, Sheffield, AL 35660 Phone: 256-381-6673 Fax: 256-381-8091 |